Trial
NCT00984165
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Hodgkin's Lymphoma
Intervention
Single fraction radiation
Why stopped
Terminated due to slow accrual, PI left NIH and primary endpoint not met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-02